Several murine metastasizing tumors possess a cysteine proteinase with cancer procoagulant characteristics

A. Falanga, A. P B Dallesandro, B. Casali

Research output: Contribution to journalArticlepeer-review


Cancer Procoagulant (CP), a cysteine proteinase which triggers blood coagulation by directly activating Factor X (FX) in the absence of Factor VII (F VII), has recently been isolated from rabbit V2 carcinoma and biochemically characterized. We have studied the procoagulant activity of tissue extracts from 4 murine experimental tumors in order to define whether or not a F VII-independent activity with cysteine proteinase characteristics was present. The tumors studied were: Lewis lung carcinoma (3LL), B16 melanoma (B16), JW sarcoma (JWS) and the M4 variant of the mFS6 fibrosarcoma (M4). Extracts from 3LL, B16 and JWS tumor initiated coagulation in both the presence and absence of F VII, their procoagulant activity was sensitive to iodoacetamide (1 mM) and mercury chloride (0.1 mM). The procoagulant of M4 extract was dependent on the presence of F VII and was not significantly affected by the cysteine proteinase inhibitors. An Ouchterlony double immunodiffusion study showed immunological cross-reactivity of all but M4 extracts to a polyclonal antibody to purified CP. The present study suggests that the procoagulant(s) present in the murine tumors 3LL, B16 and JWS are enzymatically and immunologically indistinguishable from cancer procoagulant of the rabbit V2 carcinoma.

Original languageEnglish
Pages (from-to)774-777
Number of pages4
JournalInternational Journal of Cancer
Issue number6
Publication statusPublished - 1987

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'Several murine metastasizing tumors possess a cysteine proteinase with cancer procoagulant characteristics'. Together they form a unique fingerprint.

Cite this